Genevius Health Advisors

Most growth-stage MedTech and HealthTech companies don’t stall because their product is weak.

They stall because commercialization is fragmented.

Pilots don’t convert.

Security reviews stall deals.

Clinical validation doesn’t translate into CFO-ready ROI.

Messaging resonates with clinicians — but not with budget holders.

The result?

Pipeline looks strong.

Revenue doesn’t move.

That’s not a product problem.

It’s a commercial clarity problem.

—

I work with growth-stage MedTech and HealthTech companies that are:

• Revenue-positive but stuck in long enterprise cycles

• Under board pressure to accelerate conversion

• Running pilots without auto-conversion logic

• Struggling to define the real economic buyer

My role is simple:

Install commercial clarity before execution.

The Commercial Reset Framework:

Diagnose — Define the real ICP and economic buyer.

Translate — Convert clinical value into P&L impact and reimbursement logic.

Sequence — Align GTM to how enterprise healthcare actually buys.

This is not marketing support.

It is a commercial review and reset.

Strong innovation should not stall due to narrative confusion or misaligned GTM.

If your company feels like it’s working hard but not breaking through, you don’t need more activity.

You need clarity.

→ Book a Commercial Readiness Audit

→ Or message me if you’re seeing “pilot purgatory” inside your organization.

Genevius Health Advisors

Installing Commercial Clarity before execution.